Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis

The American Journal of Pathology
Alec FalkenhamJean-Francois Légaré

Abstract

Macrophages are increasingly recognized as a potential therapeutic target in myocardial fibrosis via interactions with fibroblasts. We have characterized macrophage depletion and inhibition of nonclassical macrophage migration, in addition to direct interactions between nonclassical macrophages and fibroblasts in angiotensin II (AngII)-mediated, hypertensive myocardial fibrosis. Macrophage depletion was achieved by daily i.v. clodronate liposomes (-1 day to +3 days) during AngII infusion. Cx3cr1(-/-) mice were used to inhibit nonclassical macrophage migration. Macrophage phenotype (F4/80, CD11b, Ly6C) was characterized by immunofluorescence and flow cytometry. Collagen was assessed by Sirius Red/Fast Green. Quantitative real-time RT-PCR was performed for transcript levels. AngII/wild-type (WT) mice displayed significant infiltrate and fibrosis compared with saline/WT, which was virtually ablated by clodronate liposomes independent of hypertension. In vitro data supported M2 macrophages promoting fibroblast differentiation and collagen production. AngII/Cx3cr1(-/-) mice, however, significantly increased macrophage infiltrate and fibrosis relative to AngII/WT. AngII/Cx3cr1(-/-) mice also showed an M1 phenotypic shift relative to ...Continue Reading

References

Jan 1, 1994·Journal of Drug Targeting·A M Buiting, N Van Rooijen
Sep 7, 2000·The Journal of Biological Chemistry·F WernerM E Lee
Feb 26, 2003·Circulation·Christophe CombadièreZiad Mallat
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cord SunderkötterPieter J M Leenen
Sep 18, 2004·Circulation Research·P Christian Schulze, Richard T Lee
Dec 3, 2005·Nature Reviews. Immunology·Siamon Gordon, Philip R Taylor
Aug 1, 2006·The American Journal of Pathology·Kengo FuruichiPhilip M Murphy
Nov 18, 2006·Cardiovascular Research·Marcin Bujak, Nikolaos G Frangogiannis
Feb 27, 2007·The American Journal of Pathology·Machteld J van AmerongenMarja J A van Luyn
Nov 1, 2007·European Journal of Immunology·Siamon Gordon
Nov 21, 2007·The Journal of Experimental Medicine·Matthias NahrendorfMikael J Pittet
Dec 15, 2007·Journal of Hepatology·Hermann E WasmuthFrank Lammert
Dec 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuko IshidaPhilip M Murphy
Jun 19, 2009·Inflammation & Allergy Drug Targets·Felix HeymannFrank Tacke
Jan 15, 2010·Methods in Molecular Biology·Nico van Rooijen, Esther Hendrikx
May 8, 2010·Trends in Cardiovascular Medicine·Gabriela KaniaUrs Eriksson
Jun 1, 2010·Immunity·Siamon Gordon, Fernando O Martinez
Jun 10, 2010·Circulation·Matthias NahrendorfFilip K Swirski
Jul 14, 2010·Seminars in Nephrology·Madeleine A VernonJeremy Hughes
Aug 3, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Dmitri V PechkovskyGernot Zissel
Aug 5, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tomonori AoyamaEkihiro Seki
Oct 12, 2010·Biomaterials·Dolly J HoltDavid W Grainger
Dec 1, 2010·Laboratory Investigation; a Journal of Technical Methods and Pathology·Mryanda J SopelJean-Francois Légaré
Jan 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tamar Harel-AdarSmadar Cohen
Jan 1, 2008·CSH Protocols·Joachim Weischenfeldt, Bo Porse
Oct 11, 2011·Nature Reviews. Immunology·Chao Shi, Eric G Pamer
Nov 3, 2011·The Journal of Clinical Investigation·Oscar Medina-ContrerasTimothy L Denning
Jan 10, 2012·International Journal of Experimental Pathology·Mryanda SopelJean-Francois Légaré
Jan 20, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Nicole L RosinJean-Francois Légaré
Nov 20, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Stefan FrantzJohann Bauersachs
Jan 5, 2013·The American Journal of Pathology·Nicole L RosinJean-Francois Légaré
Mar 19, 2013·Journal of Leukocyte Biology·Margaret L Novak, Timothy J Koh
Apr 27, 2013·Nature·Thomas A WynnJeffrey W Pollard
Jun 21, 2013·Seminars in Immunopathology·Siamon Gordon, Annette Plűddemann
Aug 27, 2013·Journal of the American College of Cardiology·Tamar Ben-MordechaiJonathan Leor

❮ Previous
Next ❯

Citations

Dec 1, 2015·Frontiers in Medicine·Adhyatmika AdhyatmikaBarbro N Melgert
Jun 22, 2016·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Alec FalkenhamJean Francois Legare
Sep 14, 2016·Experimental and Molecular Pathology·Dimitry A ChistiakovYuri V Bobryshev
Dec 14, 2016·Annual Review of Physiology·Kevin M Vannella, Thomas A Wynn
Feb 1, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Joshua A WalkerKenneth C Williams
Sep 12, 2017·European Journal of Heart Failure·Yingying ZhangHarald F Langer
Jun 7, 2018·Physiological Reviews·Steven J ForresterSatoru Eguchi
Mar 10, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Lindsay T McDonaldAmy D Bradshaw
Jun 25, 2016·Circulation Research·Sarah A Dick, Slava Epelman
Nov 3, 2016·American Journal of Physiology. Lung Cellular and Molecular Physiology·John C HuetschLarissa A Shimoda
Oct 4, 2019·The Journal of Pathology·Yi-Ting ChenShuei-Liong Lin
Mar 13, 2020·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuan YueZhongkai Wu
May 27, 2020·Basic Research in Cardiology·Ilona CuijpersEbba Brakenhielm
Jul 30, 2019·International Heart Journal·Tsukasa Oshima, Katsuhito Fujiu
Apr 20, 2019·Frontiers in Immunology·Stephanie A LegereJean S Marshall
Aug 28, 2020·American Journal of Physiology. Cell Physiology·Kyoko Imanaka-YoshidaToshimichi Yoshida
Sep 10, 2015·Current Opinion in Rheumatology·Jennifer J Chia, Theresa T Lu
Dec 29, 2020·Cellular Signalling·Alexandra M GarvinTaben M Hale
Aug 1, 2018·JACC. Basic to Translational Science·Bindiya PatelSumanth D Prabhu
Sep 16, 2020·Journal of Molecular and Cellular Cardiology·Stephanie A LegereUNKNOWN IMPART Investigator Team Canada
Nov 10, 2020·Translational Research : the Journal of Laboratory and Clinical Medicine·Eliane F E WenstedtLiffert Vogt
Jul 30, 2018·Molecular Aspects of Medicine·Nikolaos G Frangogiannis
Mar 7, 2021·International Journal of Molecular Sciences·Mireia Perera-GonzalezBruno Karl Podesser
Mar 26, 2021·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Vera UsuelliPaolo Fiorina
May 14, 2021·Advanced Drug Delivery Reviews·Fabiana PassaroGianluca Testa
Aug 28, 2021·International Journal of Molecular Sciences·Ibrahim Y AbdelgawadBeshay N Zordoky
Oct 15, 2021·Molecular Biology Reports·Fatemeh SadoughiBahman Yousefi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.